225 related articles for article (PubMed ID: 34740324)
21. Next generation sequencing and its applications in HPV-associated cancers.
Tuna M; Amos CI
Oncotarget; 2017 Jan; 8(5):8877-8889. PubMed ID: 27784002
[TBL] [Abstract][Full Text] [Related]
22. Association between APOBEC3H-Mediated Demethylation and Immune Landscape in Head and Neck Squamous Carcinoma.
Liu Q; Luo YW; Cao RY; Pan X; Chen XJ; Zhang SY; Zhang WL; Zhou JY; Cheng B; Ren XY
Biomed Res Int; 2020; 2020():4612375. PubMed ID: 32775421
[TBL] [Abstract][Full Text] [Related]
23. Comprehensive analysis of immune cell enrichment in the tumor microenvironment of head and neck squamous cell carcinoma.
Mito I; Takahashi H; Kawabata-Iwakawa R; Ida S; Tada H; Chikamatsu K
Sci Rep; 2021 Aug; 11(1):16134. PubMed ID: 34373557
[TBL] [Abstract][Full Text] [Related]
24. Characterization of the tumor immune microenvironment in human papillomavirus-positive and -negative head and neck squamous cell carcinomas.
Succaria F; Kvistborg P; Stein JE; Engle EL; McMiller TL; Rooper LM; Thompson E; Berger AE; van den Brekel M; Zuur CL; Haanen J; Topalian SL; Taube JM
Cancer Immunol Immunother; 2021 May; 70(5):1227-1237. PubMed ID: 33125511
[TBL] [Abstract][Full Text] [Related]
25. The landscape of viral associations in human cancers.
Zapatka M; Borozan I; Brewer DS; Iskar M; Grundhoff A; Alawi M; Desai N; Sültmann H; Moch H; ; Cooper CS; Eils R; Ferretti V; Lichter P;
Nat Genet; 2020 Mar; 52(3):320-330. PubMed ID: 32025001
[TBL] [Abstract][Full Text] [Related]
26. Patterns of antibody responses to nonviral cancer antigens in head and neck squamous cell carcinoma patients differ by human papillomavirus status.
Gangkofner DS; Holzinger D; Schroeder L; Eichmüller SB; Zörnig I; Jäger D; Wichmann G; Dietz A; Broglie MA; Herold-Mende C; Dyckhoff G; Boscolo-Rizzo P; Ezic J; Marienfeld RB; Möller P; Völkel G; Kraus JM; Kestler HA; Brunner C; Schuler PJ; Wigand M; Theodoraki MN; Doescher J; Hoffmann TK; Pawlita M; Butt J; Waterboer T; Laban S
Int J Cancer; 2019 Dec; 145(12):3436-3444. PubMed ID: 31407331
[TBL] [Abstract][Full Text] [Related]
27. Analysis of the immune landscape in virus-induced cancers using a novel integrative mechanism discovery approach.
Wong LM; Li WT; Shende N; Tsai JC; Ma J; Chakladar J; Gnanasekar A; Qu Y; Dereschuk K; Wang-Rodriguez J; Ongkeko WM
Comput Struct Biotechnol J; 2021; 19():6240-6254. PubMed ID: 34900135
[TBL] [Abstract][Full Text] [Related]
28. NT5E upregulation in head and neck squamous cell carcinoma: A novel biomarker on cancer-associated fibroblasts for predicting immunosuppressive tumor microenvironment.
Chen XM; Liu YY; Tao BY; Xue XM; Zhang XX; Wang LL; Zhong H; Zhang J; Yang SM; Jiang QQ
Front Immunol; 2022; 13():975847. PubMed ID: 36091055
[TBL] [Abstract][Full Text] [Related]
29. HPV-positive status associated with inflamed immune microenvironment and improved response to anti-PD-1 therapy in head and neck squamous cell carcinoma.
Wang J; Sun H; Zeng Q; Guo XJ; Wang H; Liu HH; Dong ZY
Sci Rep; 2019 Sep; 9(1):13404. PubMed ID: 31527697
[TBL] [Abstract][Full Text] [Related]
30. Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck Cancer.
Murphy RM; Tasoulas J; Porrello A; Carper MB; Tsai YH; Coffey AR; Kumar S; Zeng PY; Schrank TP; Midkiff BR; Cohen S; Salazar AH; Hayward MC; Hayes DN; Olshan A; Gupta GP; Nichols AC; Yarbrough WG; Pecot CV; Amelio AL
Cancer Res Commun; 2022 Sep; 2(9):987-1004. PubMed ID: 36148399
[TBL] [Abstract][Full Text] [Related]
31. Differences in gastric carcinoma microenvironment stratify according to EBV infection intensity: implications for possible immune adjuvant therapy.
Strong MJ; Xu G; Coco J; Baribault C; Vinay DS; Lacey MR; Strong AL; Lehman TA; Seddon MB; Lin Z; Concha M; Baddoo M; Ferris M; Swan KF; Sullivan DE; Burow ME; Taylor CM; Flemington EK
PLoS Pathog; 2013; 9(5):e1003341. PubMed ID: 23671415
[TBL] [Abstract][Full Text] [Related]
32. Integrated multi-omics analysis identifies CD73 as a prognostic biomarker and immunotherapy response predictor in head and neck squamous cell carcinoma.
Shen A; Ye Y; Chen F; Xu Y; Zhang Z; Zhao Q; Zeng ZL
Front Immunol; 2022; 13():969034. PubMed ID: 36466881
[TBL] [Abstract][Full Text] [Related]
33. The influence of human papillomavirus on nasopharyngeal carcinoma in Japan.
Kano M; Kondo S; Wakisaka N; Moriyama-Kita M; Nakanishi Y; Endo K; Murono S; Nakamura H; Yoshizaki T
Auris Nasus Larynx; 2017 Jun; 44(3):327-332. PubMed ID: 27499435
[TBL] [Abstract][Full Text] [Related]
34. PYHIN genes as potential biomarkers for prognosis of human papillomavirus-positive or -negative head and neck squamous cell carcinomas.
Riva G; Pecorari G; Biolatti M; Pautasso S; Lo Cigno I; Garzaro M; Dell'Oste V; Landolfo S
Mol Biol Rep; 2019 Jun; 46(3):3333-3347. PubMed ID: 30980272
[TBL] [Abstract][Full Text] [Related]
35. Detection of human papillomavirus in cases of head and neck squamous cell carcinoma by RNA-seq and VirTect.
Khan A; Liu Q; Chen X; Stucky A; Sedghizadeh PP; Adelpour D; Zhang X; Wang K; Zhong JF
Mol Oncol; 2019 Apr; 13(4):829-839. PubMed ID: 30597724
[TBL] [Abstract][Full Text] [Related]
36. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
Zhang X; Wang Y; A G; Qu C; Chen J
Front Immunol; 2021; 12():721030. PubMed ID: 34531868
[TBL] [Abstract][Full Text] [Related]
37. Detection of Epstein-Barr virus and human papillomavirus in head and neck tumors.
Tyan YS; Liu ST; Ong WR; Chen ML; Shu CH; Chang YS
J Clin Microbiol; 1993 Jan; 31(1):53-6. PubMed ID: 8380183
[TBL] [Abstract][Full Text] [Related]
38. HPV and EBV Infections in Neck Metastases from Occult Primary Squamous Cell Carcinoma: Another Virus-Related Neoplastic Disease in the Head and Neck Region.
Bussu F; Sali M; Gallus R; Petrone G; Autorino R; Santangelo R; Pandolfini M; Miccichè F; Delogu G; Almadori G; Galli J; Sanguinetti M; Rindi G; Tommasino M; Valentini V; Paludetti G
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S979-84. PubMed ID: 26286196
[TBL] [Abstract][Full Text] [Related]
39. Molecular Subtypes Based on Cell Differentiation Trajectories in Head and Neck Squamous Cell Carcinoma: Differential Prognosis and Immunotherapeutic Responses.
Huang ZD; Liu ZZ; Liu YY; Fu YC; Lin LL; Hu C; Gu HY; Wei RX
Front Immunol; 2021; 12():791621. PubMed ID: 35003112
[TBL] [Abstract][Full Text] [Related]
40. The HPV Induced Cancer Resource (THInCR): a Suite of Tools for Investigating HPV-Dependent Human Carcinogenesis.
Salnikov M; Gameiro SF; Zeng PYF; Barrett JW; Nichols AC; Mymryk JS
mSphere; 2022 Aug; 7(4):e0031722. PubMed ID: 35950764
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
